Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fluorescence in Situ Hybridization (FISH) Improves Performance of Conventional Cytology for the Diagnosis of Malignant Biliary Tract Strictures in Thai Patients

NCT02442167 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02442167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02442167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fluorescence in Situ Hybridization (FISH) Improves Performance of Conventional Cytology for the Diagnosis of Malignant Biliary Tract Strictures in Thai Patients
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
March 31, 2010
Completion date
December 31, 2014
Enrollment
101 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bile duct stricture, malignancy